Who owns HALO?
Institutional ownership of Halozyme Therapeutics Inc. from Form 13F, Q2 2026
668 institutional managers reported holding Halozyme Therapeutics Inc. (HALO) in Form 13F filings for Q2 2026, with 124,242,474 shares worth $9.7B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 3,962,240 shares (+3.3%). 98 opened new positions and 66 sold out.
- Funds holding
- 668
- Value held
- $9.7B
- New / sold out
- 98 / 66
- Net shares, same filers
- +3.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of HALO
Share of 13F holdings is each fund's shares as a share of the 124,242,474 HALO shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Assenagon Asset Management S.A. Added+$155M
- Norges Bank New+$116M
- Los Angeles Capital Management LLC Added+$97.7M
- Mizuho Markets Cayman LP New+$65.3M
- UBS Group AG Added+$45.3M
- Goldman Sachs Group Inc Added+$42.3M
- Wedge Capital Management L L P New+$31.6M
- Boston Trust Walden Corp Added+$31.6M
- Frontier Capital Management Co LLC New+$26.8M
- Price T Rowe Associates Inc Added+$22.0M
Biggest sellers in Q2 2026
- Jupiter Asset Management LTD Trimmed-$118M
- Mizuho Markets Americas LLC Trimmed-$72.8M
- Invesco Ltd. Trimmed-$65.3M
- Capital World Investors Sold out-$56.4M
- ArrowMark Colorado Holdings LLC Trimmed-$37.0M
- Jacobs Levy Equity Management, Inc Trimmed-$36.6M
- Millennium Management LLC Trimmed-$35.3M
- Empowered Funds, LLC Trimmed-$23.2M
- Voloridge Investment Management, LLC Sold out-$20.1M
- Renaissance Technologies LLC Trimmed-$19.7M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $1.1B and sold $803M; 266 added and 201 trimmed.
Schedule 13D and 13G filings on HALO
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-05-13STATE STREET CORP SCHEDULE 13G filed by Halozyme Therapeutics Inc.Schedule 13G
Questions about HALO ownership
- Who owns HALO stock?
- 668 institutional investment managers reported HALO positions in their Form 13F filings for Q2 2026, holding 124,242,474 shares worth $9.7B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling HALO?
- In Q2 2026, 98 managers opened new HALO positions, 266 added, 201 trimmed and 66 sold out. Managers that filed in both quarters added a net 3,962,240 shares.
- How current is this HALO institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to HALO by CUSIP. Options are left out. HALO news and filings · HALO insider trades · Top funds